Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 5, 2008, Pages 1979-1982

  Cordeiro, Cynthia A ^a,b   Moreira, Paula R ^a   Andrade, Mariana S ^a   Dutra, Walderez O ^a   Campos, Wesley R ^a   Oréfice, Fernando ^a   Teixeira, Antônio L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERLEUKIN 10; RESTRICTION ENDONUCLEASE;

ADULT; ALLELE; ARTICLE; BLOOD DONOR; CHORIORETINITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RESTRICTION MAPPING; SEROLOGY; THROAT CULTURE; TOXOPLASMOSIS; VISUAL ACUITY; GENETICS; PARASITOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHORIORETINITIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TOXOPLASMOSIS, OCULAR;

EID: 44649107255     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1393     Document Type: Article

References (24)

1. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136: 973-988.
2. Oréfice F. Uveíte: Cĺinica e Cirúrgica: Texto e Atlas. 2nd ed. Rio de Janeiro, Brazil: Cultura Médica; 2005:1484.
3. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121:35-46.
4. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103:131-136.
5. McMenamin PG, Dutton GN, Hay J, Cameron S. The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: The localization and morphology of Toxoplasma cysts in the retina. Exp Eye Res. 1986;43:529-543.
6. Vallochi AL, Nakamura MV, Schlesinger D, et al. Ocular toxoplasmosis: more than just what meets the eye. Scand J Im-minol. 2002;55:324-328.
7. Takase H, Futagami Y, Yoshida T, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uve- itis. Invest Ophthalmol Vis Sci. 2006;47:1557-1561.
8. Goncalves RM, Rodrigues DH, Camargos da Costa AM, et al. Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis. Acta Ophthalmol Scand. 2007:85;871-876.
9. Lazarus M, Hajeer AH, Turner D, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol. 1997;24:2314-2317.
10. Groux H, Bigler M, de Vries JE, Roncarolo MG. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol. 1998;160:3188-3193.
11. Neyer LE, Grunig G, Fort M, Remington JS, Rennick D, Hunter CA. Role of interleukin-10 in regulation of T-cell-dependent and T-cell- independent mechanisms of resistance to Toxoplasma gondii. In- fectImmun. 1997;65:1675-1682.
12. Lazarus R, Klimecki WT, Palmer LJ, et al. Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics. 2002;80:223-228.
13. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleu- kin-10 gene promoter. Eur JImmunogenet. 1997;24:1-8.
14. Wallace GR, Kondeatis E, Vaughan RW, et al. IL-10 genotype analysis in patients with Behcet's disease. Hum Immunol. 2007; 68:122-127.
15. Castro-Santos P, Suarez A, López-Rivas L, Mozo L, Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease: association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol. 2006;101:1039-1047.
16. Sainz J, Hassan L, Perez E, Romero A, et al. Interleukin-10 promoter olymorphism as risk factor to develop invasive pulmonary as- pergillosis. Immunol Lett. 2007;109:76-82.
17. Seo KW, Kim DH, Sohn SK, et al. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant. 2005;36:1089-1095.
18. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group; standardization of uveitis nomenclature for reporting clinical data-results of the First International Workshop. Am J Ophthalmol. 2005;140:509-516.
19. Hunter CA, Abrams JS, Beaman MH, Remington JS. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun. 1993;61:4038-4044.
20. Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 1996;157:798 -805.
21. Lu F, Huang S, Kasper LH. Interleukin-10 and pathogenesis of murine ocular toxoplasmosis. Infect Immun. 2003;71:7159-7163.
22. Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659-2665.
23. Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci. 2005;46:4245-4250.
24. Stanford MR, Vaughan RW, Kondeatis E, et al. Are cytokine gene polymorphisms associated with outcome in patients with idio- pathic intermediate uveitis in the United Kingdom? Br J Ophthalmol. 2005;89:1013-1016.